You are here

Specifications

19 August 2021

If you intend to rely on any legislation referred to on this website, you should access copies of the official versions. These instruments are amended from time to time and may, on occasions, be replaced or new instruments made.

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

2021

  • Therapeutic Goods (Medicinal Cannabis Products) (Information) Specification 2021
    Specifies the publication of aggregated and de-identified statistical information; being, the numbers of applications or notifications (collectively, “submissions”) made in relation to medicinal cannabis products under the Authorised Prescriber, Special Access Scheme Category A and Special Access Scheme Category B pathways in Australia. The aggregated and deidentified statistical information made available through the instrument includes: time periods; the relevant state or territory in which the medicinal cannabis products are prescribed; the indications for which the products have been prescribed; the active ingredients relating to those products; and the status of the submissions (such as approved, withdrawn, refused, pending or received).

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

  • Restricted Medicine Specification 2011
    Specifies under subsections 3(2A) & 3(2B) of the Therapeutic Goods Act 1989, medicines or classes of medicine for the purposes of the definition of restricted medicine in subsection 3(1)